Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies
Clinical trial NCT07485504 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07485504
- Sponsor
- Tcelltech Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-15
- Primary completion
- 2028-10-15
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.